Targeting FGFR in non-small cell lung cancer: implications from the landscape of clinically actionable aberrations of FGFR kinases

Targeting FGFR in non-small cell lung cancer: implications from the landscape of clinically actionable aberrations of FGFR kinases

Objective: Dysfunction in fibroblast growth factor receptor (FGFR) signaling has been reported in diverse cancer types, including non-small cell lung cancer (NSCLC). The frequency of FGFR aberrations in Chinese NSCLC patients is therefore of great clinical significance. Methods: A total of 10,966 NS...

Full description

Bibliographic Details
Main Authors: Zhen Zhou, Zichuan Liu, Qiuxiang Ou, Xue Wu, Xiaonan Wang, Yang Shao, Hongyan Liu, Yu Yang
Format: Article
Language:English
Published: China Anti-Cancer Association 2021-05-01
Series:Cancer Biology & Medicine
Subjects:
fgfr
oncogenic mutation
fusion
gene amplification
targeted therapy
Online Access:http://www.cancerbiomed.org/index.php/cocr/article/view/1809

Internet

http://www.cancerbiomed.org/index.php/cocr/article/view/1809

Similar Items